FDA detects banned ingredient in several nail Care products

FDA tests revealed the presence of methylene chloride, a solvent classified as potentially carcinogenic

24 of April of 2025
Save
FDA
FDA

The United States Food and Drug Administration (FDA) has found a prohibited chemical compound in several gel nail polish remover products, after analyzing samples marketed in pharmacies and beauty stores.

Tests conducted by the FDA revealed the presence of methylene chloride (dichloromethane), a solvent classified as potentially carcinogenic and whose use has been banned in cosmetic products in the United States since 2012. This compound facilitates the rapid removal of hardened gel layers, but exposes the user to inhalation of toxic vapors and skin poisoning.

According to the agency, at least four imported brands are involved in the violation of federal regulations. Although the manufacturers have not been publicly identified, the FDA has notified distributors to immediately remove the affected batches from the market and issue safety alerts to consumers.

Inhalation of methylene chloride can cause nausea, headache, dizziness, and even damage to the central nervous system. In prolonged exposures or high concentrations, the compound increases the risk of cancer and liver damage. The FDA recommends adequately ventilating application areas and, in the event of any adverse symptoms, consulting a healthcare professional.

Several supply chains and distributors of manicure products have initiated internal audits to ensure compliance with regulations. Some firms have announced the strengthening of their quality controls and the revision of the certificates of their international suppliers.

The FDA continues to inspect imports and sends additional samples to the laboratory to confirm whether there are more contaminated batches. It also evaluates possible administrative sanctions and fines against companies responsible for introducing a product that does not comply with current legislation to the market.